Differential sensitivity of MCF-7 and LCC2 cells, to multiple growth inhibitory agents: possible relation to high bcl-2/bax ratio?
- 1 December 2000
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 161 (1) , 27-34
- https://doi.org/10.1016/s0304-3835(00)00579-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostainingHistopathology, 1999
- Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with ApoptosisJournal of Biological Chemistry, 1998
- bcl-2 antisense therapy chemosensitizes human melanoma in SCID miceNature Medicine, 1998
- Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagyCarcinogenesis: Integrative Cancer Research, 1996
- Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistanceCurrent Opinion in Oncology, 1995
- Bcl‐2 expression is associated with lymph node metastasis in human ductal breast carcinomaInternational Journal of Cancer, 1995
- Effects of BCL-2 antisense oligodeoxynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cellsBlood, 1994
- c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast CancerNew England Journal of Medicine, 1994
- bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancerBritish Journal of Cancer, 1994
- Hormone resistance, invasiveness, and metastatic potential in breast cancerBreast Cancer Research and Treatment, 1993